Advancing new innovative approaches for cancer treatment

Understanding of the biological mechanisms of cancer is increasing, and research in oncology is advancing rapidly. Orion Pharma develops new cancer drugs and treatments with the aim of improving outcomes for patients.

We are committed to developing better treatments for cancer patients through deeper understanding of disease biology and treatment resistance.

Our focus has been particularly on hormone-mediated cancers such as prostate cancer. Now our global ambition is to develop new and effective treatments for solid tumours as we advance both small molecule and biologic drug candidates through the clinic. 

By improving understanding of tumour biology and mechanisms driving disease progression, we aim to identify new opportunities for more targeted and effective treatments.